Biomarker: E005-IgE Dog Dander

Overview

E005-IgE Dog Dander measures serum immunoglobulin E (IgE) antibodies directed against dog dander allergens. IgE is an antibody involved in immediate hypersensitivity reactions, including allergic rhinitis, conjunctivitis, asthma, and some skin reactions. A detectable or elevated result indicates sensitization to dog allergens, but does not by itself prove that exposure causes clinical symptoms or predict reaction severity. The test is clinically useful when interpreted with exposure history, symptoms, physical examination, and, when appropriate, skin-prick or component-resolved testing.

Clinical Use Cases

Evaluating suspected allergy symptoms associated with exposure to dogs, including allergic rhinitis, conjunctivitis, asthma, urticaria, or contact-related skin symptoms.
Supporting assessment of sensitization to dog allergens when skin testing is unsuitable, unsafe, or affected by medications or skin disease.
Differentiating dog sensitization from sensitization to other indoor or environmental allergens.
Supporting evaluation of respiratory symptoms in patients with suspected animal-allergen exposure.
Contributing to research on associations between dog-specific IgE, allergic symptoms, asthma, and allergen exposure.
Guiding further evaluation with specific dog allergen components, such as Can f 1, Can f 2, Can f 3, Can f 5, or Can f 6, when clinically indicated.

Specimen Types

Venous blood, typically tested as serum.
Plasma may be accepted by some validated laboratory platforms, depending on the assay.

Measurement Methods

Automated in-vitro allergen-specific IgE immunoassays using dog dander extract.
Fluorescence enzyme immunoassay or related solid-phase immunoassay methods.
Radioallergosorbent test, or RAST-type methods, mainly as an older assay category.
Component-resolved immunoassays for individual dog allergens, including Can f 1 through Can f 6, when available.
Results are commonly reported in kUA/L or kU/L and may be assigned an assay-specific class or category. Cutoffs and analytical performance vary by platform, so results from different assays should not be considered directly interchangeable.

Test Preparation and Influencing Factors

No fasting or other special preparation is usually required for a blood-based specific-IgE test.
Patients should provide a complete list of prescription medicines, over-the-counter medicines, vitamins, and supplements.
Antihistamines commonly interfere with skin-prick testing but generally do not prevent measurement of serum-specific IgE. Medication changes should be made only on the advice of a healthcare professional.
Recent or ongoing exposure to dogs does not generally require avoidance before blood collection.
Total IgE concentration, age, atopic status, assay characteristics, and the selected reporting cutoff may influence interpretation.
Cross-reactive allergen components, including some animal proteins and cross-reactive carbohydrate determinants, may contribute to positive results without clear clinical reactivity.
A positive result indicates immunologic sensitization, not necessarily symptomatic allergy. Clinical interpretation requires compatible symptoms during or after relevant exposure.
The numeric IgE concentration does not reliably predict the severity of an individual’s allergic reaction.
Results may differ between assay platforms because allergen preparations, calibration, and detection characteristics are not fully interchangeable.